These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 24159258

  • 1. SOSPES: SPIRIVA® observational study measuring SGRQ score in routine medical practice in Central and Eastern Europe.
    Fležar M, Jahnz-Różyk K, Enache G, Martynenko T, Kristufek P, Škrinjarić-Cincar S, Kadlecová P, Martinovic G.
    Int J Chron Obstruct Pulmon Dis; 2013; 8():483-92. PubMed ID: 24159258
    [Abstract] [Full Text] [Related]

  • 2. Early impact of treatment with tiotropium, long-acting anticholinergic preparation, in patients with COPD - real-life experience from an observational study.
    Jahnz-Różyk K, Szepiel P.
    Int J Chron Obstruct Pulmon Dis; 2015; 10():613-23. PubMed ID: 25834420
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of combining olodaterol Respimat(®) and tiotropium HandiHaler(®) in patients with COPD: results of two randomized, double-blind, active-controlled studies.
    ZuWallack R, Allen L, Hernandez G, Ting N, Abrahams R.
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1133-44. PubMed ID: 25342898
    [Abstract] [Full Text] [Related]

  • 4. Impact of tiotropium + olodaterol on physical functioning in COPD: results of an open-label observational study.
    Sauer R, Hänsel M, Buhl R, Rubin RA, Frey M, Glaab T.
    Int J Chron Obstruct Pulmon Dis; 2016; 11():891-8. PubMed ID: 27217742
    [Abstract] [Full Text] [Related]

  • 5. The efficacy and safety of combined tiotropium and olodaterol via the Respimat(®) inhaler in patients with COPD: results from the Japanese sub-population of the Tonado(®) studies.
    Ichinose M, Taniguchi H, Takizawa A, Grönke L, Loaiza L, Voß F, Zhao Y, Fukuchi Y.
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2017-27. PubMed ID: 27621608
    [Abstract] [Full Text] [Related]

  • 6. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.
    Keam SJ, Keating GM.
    Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163
    [Abstract] [Full Text] [Related]

  • 7. Tiotropium bromide, a new, once-daily inhaled anticholinergic bronchodilator for chronic-obstructive pulmonary disease.
    ZuWallack AR, ZuWallack RL.
    Expert Opin Pharmacother; 2004 Aug; 5(8):1827-35. PubMed ID: 15264997
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Tiotropium versus placebo for chronic obstructive pulmonary disease.
    Karner C, Chong J, Poole P.
    Cochrane Database Syst Rev; 2012 Jul 11; (7):CD009285. PubMed ID: 22786525
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Tiotropium and exercise training in COPD patients: effects on dyspnea and exercise tolerance.
    Ambrosino N, Foglio K, Balzano G, Paggiaro PL, Lessi P, Kesten S, Tiotropium Multicentric Italian Study Group.
    Int J Chron Obstruct Pulmon Dis; 2008 Jul 11; 3(4):771-80. PubMed ID: 19281092
    [Abstract] [Full Text] [Related]

  • 13. Effects of baseline symptom burden on treatment response in COPD.
    Martinez FJ, Abrahams RA, Ferguson GT, Bjermer L, Grönke L, Voß F, Singh D.
    Int J Chron Obstruct Pulmon Dis; 2019 Jul 11; 14():181-194. PubMed ID: 30655665
    [Abstract] [Full Text] [Related]

  • 14. Safety and efficacy of the once-daily anticholinergic BEA2180 compared with tiotropium in patients with COPD.
    Abrahams R, Moroni-Zentgraf P, Ramsdell J, Schmidt H, Joseph E, Karpel J.
    Respir Med; 2013 Jun 11; 107(6):854-62. PubMed ID: 23490224
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Tiotropium HandiHaler(®) and Respimat(®) in COPD: a pooled safety analysis.
    Halpin DM, Dahl R, Hallmann C, Mueller A, Tashkin D.
    Int J Chron Obstruct Pulmon Dis; 2015 Jun 11; 10():239-59. PubMed ID: 25709423
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Consistent improvement in health-related quality of life with tiotropium in patients with chronic obstructive pulmonary disease: Novel and conventional responder analyses.
    Tashkin DP, Bateman ED, Jones P, Zubek VB, Metzdorf N, Liu D, Leonard T, Clerisme-Beaty E, Wise RA.
    Respir Med; 2016 Nov 11; 120():91-100. PubMed ID: 27817821
    [Abstract] [Full Text] [Related]

  • 20. Tiotropium Respimat® improves physical functioning in chronic obstructive pulmonary disease.
    Rau-Berger H, Mitfessel H, Glaab T.
    Int J Chron Obstruct Pulmon Dis; 2010 Oct 10; 5():367-73. PubMed ID: 21103403
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.